• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD INSYTE¿ AUTOGUARD¿ BC SHIELDED IV CATHETERS; INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD INSYTE¿ AUTOGUARD¿ BC SHIELDED IV CATHETERS; INTRAVASCULAR CATHETER Back to Search Results
Catalog Number 382933
Device Problem Packaging Problem (3007)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/17/2022
Event Type  malfunction  
Manufacturer Narrative
A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported by the customer that 5 of the bd insyte¿ autoguard¿ bc shielded iv catheters was not sealed and had black paper at the end.The following information was provided by the initial reporter: while counting out material on our kitting line the operators found 5 catheters with the blister packs not sealed.The blister pack had black paper at the end of the pack which we suspect may prevented the correct sealing of the blister (see attached photo).
 
Manufacturer Narrative
H6: investigation summary a physical sample was not available for investigation but bd was provided with two photos of the issue for evaluation.A review of the device history record was performed for the reported lot, 2129667, and no quality issues were found during production.Our quality engineer reviewed the provided photos and observed five 20 gauge insyte autoguard bc pro winged devices with black tape on the underside of the packaging.The five units appeared to be opened where the tape was present.Therefore, based off the provided photos the engineer was able to verify the reported defect.H3 other text : see h10.
 
Event Description
It was reported by the customer that 5 of the bd insyte¿ autoguard¿ bc shielded iv catheters was not sealed and had black paper at the end.The following information was provided by the initial reporter: while counting out material on our kitting line the operators found 5 catheters with the blister packs not sealed.The blister pack had black paper at the end of the pack which we suspect may prevented the correct sealing of the blister (see attached photo).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD INSYTE¿ AUTOGUARD¿ BC SHIELDED IV CATHETERS
Type of Device
INTRAVASCULAR CATHETER
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer (Section G)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key15955937
MDR Text Key308075342
Report Number1710034-2022-00783
Device Sequence Number1
Product Code FOZ
Combination Product (y/n)N
Reporter Country CodeEI
PMA/PMN Number
K201075
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 01/12/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/10/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number382933
Device Lot Number2129667
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/12/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/17/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-